K

Kuwait Life Sciences Company (KLSC)

21 employees

KLSC aims to be the Middle East’s premiere Life Sciences and Healthcare technology transfer and investment company

Investor insights

Sectors invested in

Health Care2
Medical Device2
Manufacturing2
Haemodialysis1
Biotechnology1
Clinical Trials1
Medical1
Women's Healthcare1
Ultrasound1
Gastroenterology1
General Imaging1
Liver1
Hepatology1
Vascular1
Breast Imaging1
Radiology1
Chronic Kidney Disease1
Home Hemodialysis1
Home Haemodialysis1
End Stage Renal Disease1

Funding rounds participated in

$40M sweet spot round size

Most of their 4 investments are in rounds between $12M and $43M

Basic info

Industry

venture capital and private equity principals

Sectors

Health Diagnostics
Advanced Healthcare Training CME/CPD
Health Care
Middle East Life Sciences Opportunities
Medical Devices & Diagnostics Commercialization
mHealth
Clinical Research Organization (CRO)
Venture Capital & Private Equity
Information Technology

Date founded

2010

Investments made

Q

Quanta Dialysis Technologies raised $43M on November 3, 2014

Investors: Wellington Partners, Seroba-Kernel Ltd (Ireland), b-to-v Partners AG, NBGI Private Equity and Kuwait Life Sciences Company (KLSC)

U

Undisclosed raised $48M on May 29, 2013

Investors: Elan Pharmaceuticals, - and Kuwait Life Sciences Company (KLSC)

S

SuperSonic Imagine raised $36M on April 2, 2013

Investors: NBGI Private Equity, Wellington Partners, Omnes, iXO Private Equity, Auriga Partners, La Caisse des Dépôts (French financial institute) and Kuwait Life Sciences Company (KLSC)

U

Undisclosed raised $12M on September 20, 2010

Investors: - and Kuwait Life Sciences Company (KLSC)

FAQ